Sindhu R Johnson
Overview
Explore the profile of Sindhu R Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
195
Citations
6263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Rheumatol
. 2024 Jul;
76(8):1182-1200.
PMID: 38978310
Objective: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). Methods: We developed clinically relevant population, intervention, comparator, and...
12.
Mirza R, Bolster M, Johnson S, Allen Jr A, Bernstein E, Chung J, et al.
Arthritis Care Res (Hoboken)
. 2024 Jul;
76(8):1083-1089.
PMID: 38973747
Objective: Patient engagement is critical to clinical practice guideline (CPG) development. This work presents our approach to ascertaining patients' values and preferences to inform the American College of Rheumatology guidelines...
13.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Care Res (Hoboken)
. 2024 Jul;
76(8):1051-1069.
PMID: 38973731
Objective: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). Methods: We developed clinically relevant population, intervention, comparator, and...
14.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Care Res (Hoboken)
. 2024 Jul;
76(8):1070-1082.
PMID: 38973729
Objective: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic...
15.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Rheumatol
. 2024 Jul;
76(8):1201-1213.
PMID: 38973714
Objective: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic...
16.
Aboabat A, Aldohan M, Cheung P, Orchanian-Cheff A, Johnson S
J Rheumatol
. 2024 Jun;
51(8):744-751.
PMID: 38825361
Objective: Concerns regarding offering radiotherapy to patients with systemic sclerosis (SSc) stem from the potential worsening of SSc manifestations and radiotherapy toxicity. We conducted a systematic review to evaluate the...
17.
Tarannum S, Widdifield J, Wu C, Johnson S, Rochon P, Eder L
J Rheumatol
. 2024 May;
51(7):703-707.
PMID: 38692668
Objective: The aim of our study was to compare dispensation of rheumatic medications between older male and female patients with early rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Methods: This...
18.
Jackson L, Saag K, Johnson S, Danila M
J Bone Miner Res
. 2024 Mar;
39(4):425-432.
PMID: 38477794
Osteoporosis and fragility fractures are managed by clinicians across many medical specialties. The key competencies of clinicians delivering bone health care have not been systematically established. We aimed to develop...
19.
Khanna D, Kramer F, Hofler J, Ghadessi M, Sandner P, Allanore Y, et al.
Rheumatology (Oxford)
. 2024 Mar;
63(11):3124-3134.
PMID: 38460548
Objective: To examine disease and target engagement biomarkers in the RISE-SSc trial of riociguat in early diffuse cutaneous systemic sclerosis and their potential to predict the response to treatment. Methods:...
20.
Jazayeri H, Gignac M, Ahmad Z, Johnson S
J Rheumatol
. 2024 Feb;
51(6):622-627.
PMID: 38359939
Objective: Systemic sclerosis (SSc) can restrict employment participation. Our objectives were to comparatively evaluate health factors, work factors, and workplace accommodations between those who are employed and those who recently...